MVA-vectored HPV vaccine component
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for MVA-vectored HPV vaccine component, covering 2021-11-09 to 2021-11-09. Get the full timeline:
Most recent: Clinical Trial Update: Safety, Reactogenicity and Immunogenicity of Adenovirus Serotype 26 (Ad26)- and Modified Vaccinia Ankara (MVA)-Vectored Vaccine Components in Otherwise Healthy Women With HPV16 or HPV18 Infection of the Cervix [Phase 1, Phase 2]